- ESHAP Salvage Therapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
-
Choi CW, Paek CW, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS
- KMID: 1127252
- J Korean Med Sci.
- 2002 Oct;17(5):621-624.
- doi: 10.3346/jkms.2002.17.5.621
The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine (ara-C), and cisplatin, has been shown to be active against refractory or relapsed non-Hodgkin's lymphoma... -
- CITED
-
- Close
- SHARE
-
- Close
- The use of cytosine arabinoside in glaucoma filtering surgery
-
Wee WR, Youn DH
- KMID: 2270692
- Korean J Ophthalmol.
- 1992 Dec;6(2):62-68.
- doi: 10.3341/kjo.1992.6.2.62
Posterior lip sclerectomies were performed in rabbits and cytosine arabinoside (Ara-C) was applied by topical instillation or subconjunctival injection. In both groups, the mean intraocular pressure (IOP) of the treated... -
- CITED
-
- Close
- SHARE
-
- Close
- GM-CSF and low-dose araC treatment of AML in prolonged hypoplasia with residual leukemic cells after induction chemotherapy
-
Min YH, Kim SE, Lee ST, Lee SJ, Hahn JS, Ko YW
- KMID: 1381222
- Yonsei Med J.
- 1994 Mar;35(1):91-96.
- doi: 10.3349/ymj.1994.35.1.91
We describe a case with acute myelogenous leukemia (AML; M2) who developed prolonged marrow hypoplasia with residual leukemic blasts and recurrent infections after induction chemotherapy. He was treated successfully with... -
- CITED
-
- Close
- SHARE
-
- Close
